Medicinal Product Registration in Egypt

Posted 26 June 2017 By Shweta Menon

placeholder+image This article provides an overview of Egypt's New Drug Application (NDA) procedure for imported brand pharmaceutical products, including new chemical entities and biologics. It discusses the various Egyptian Drug Authority (EDA) departments and the required procedures for moving products through registration and into the market.

Share this article:

Categories: Biologics and biotechnology, Drugs, Medical Devices, Submission and registration, Features

Tags: EDA, Egyptian Drug Authority

Regulatory Exchange: Latest Updates From the Community